drugset / Trial / NCT01251003
Safety Study of Umbilical Cord Blood To Treat Pediatric Traumatic Brain Injury
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if it is safe to use stored autologous Human Umbilical Cord Blood (hUCB) to treat pediatric patients that sustain a severe or moderate Traumatic Brain Injury (TBI), and have not fully recovered as measured by the Glasgow Outcome Score-Expanded (GOS-EC)/Child at 6 to 18 months post-injury.
Timeline
- Start
- 2011-01
- Primary completion
- 2014-12
- Completion
- 2015-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Autologous cord blood | Cell therapy | 1e+10 cells/kg | Intravenous |